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Summary: Burden of Disease studies can help policy makers set priorities for health care spending and 
resource management. To date, there appears to be relatively few pieces of published research examining 
the economic cost of post- traumatic stress disorder (PTSD). The purpose of this review is to collate and 
synthesis contemporary research that looks at the economic burden of PTSD. PTSDPubs, the Cumulative 
Index of Nursing and Allied Health Literature (CINAHL), PubMed and Psych Info were used to identify 
studies reporting the economic cost of PTSD. Keywords used were “Cost of Illness” OR “Economic burden 
of disease” in PTSDPubs. “Cost of Illness”, “Burden of Disease” “PTSD” and “Psychological Trauma. 
Three studies were identified that reported the cost of PTSD. All of which report that the economic cost of 
PTSD is substantial. There are a number of limitations with these studies and further research from a 
societal perspective is required. 
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The Economic Burden of PTSD. A brief 
review of salient literature. 
 
Studies examine the economic burden of 
disease can be used to help policy makers set 
priorities for healthcare research and service 
provision [1]. These study types seek to 
quantify the economic impact of disease 
regardless of its origin or presentation. As such, 
policy makers are afforded the information 
allowing them to make decisions across and 
within therapeutic fields. Health economics 
deals with the scarcity of resources. Having 
accurate information about the economic cost 
of an illness helps policy makers prioritize, 
eventually leading to the allocation of 
healthcare resources [2]. 
 
Classified as an anxiety disorder, Post- 
Traumatic Stress Disorder (PTSD) is a 
condition that can have a significant negative 
impact on a person’s life [3]. The symptoms of 
PTSD include flashbacks, intrusive thoughts 
and nightmares, rumination and avoidance of 
areas or circumstances (WHO 2017). Figure 1 
shows the ICD-10 (WHO 1992) diagnostic 
criteria for PTSD. Psychological trauma is 
associated with a number of mental health 
issues including schizophrenia [4], eating 
disorders [5] and addictions [6]. In recent years 
a link between PTSD and physical illnesses 
such as Type II diabetes [7], cardio-vascular 
disease [8], certain cancers [9] and 
fibromyalgia [10] has been noted in the 
literature.  General population studies estimated 
a prevalence rate of PTSD of 3.6% (WHO 
2013). The lifetime prevalence of PTSD in 
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Vietnam War veterans was 16.9% [11] and a 
study of Canadian service veterans of the Iran 
war showed a prevalence of 12.9% [12]. UK 
service personnel returning from Iraq and 
Afghanistan report PTSD in 4% of cases [13]. 
In counties that have experienced civil conflict, 
the rates of PTSD are reported as 8.8% [14]. 
Given the wide-ranging impact then of PTSD, 
it is appropriate to examine the economic 
impact that PTSD has. 
 
F43.1 Post-traumatic Stress Disorder 
Arises as a delayed or protracted response to a stressful event or situation (of either brief or long duration) of an 
exceptionally threatening or catastrophic nature, which is likely to cause pervasive distress in almost anyone. 
Predisposing factors, such as personality traits (e.g. compulsive, asthenic) or previous history of neurotic illness, 
may lower the threshold for the development of the syndrome or aggravate its course, but they are neither 
necessary nor sufficient to explain its occurrence. Typical features include episodes of repeated reliving of the 
trauma in intrusive memories ("flashbacks"), dreams or nightmares, occurring against the persisting background 
of a sense of "numbness" and emotional blunting, detachment from other people, unresponsiveness to 
surroundings, anhedonia, and avoidance of activities and situations reminiscent of the trauma. There is usually a 
state of autonomic hyperarousal with hypervigilance, an enhanced startle reaction, and insomnia. Anxiety and 
depression are commonly associated with the above symptoms and signs, and suicidal ideation is not infrequent. 
The onset follows the trauma with a latency period that may range from a few weeks to months. The course is 
fluctuating but recovery can be expected in the majority of cases. In a small proportion of cases the condition may 
follow a chronic course over many years, with eventual transition to an enduring personality change. 
F43.1 Post-traumatic stress disorder 
Diagnostic Criteria 
A.     Exposure to a stressful event or situation (either short or long lasting) of exceptionally threatening or 
catastrophic nature, which is likely to cause pervasive distress in almost anyone. 
B.      Persistent remembering or "reliving" the stressor by intrusive flash backs, vivid memories, recurring 
dreams, or by experiencing distress when exposed to circumstances resembling or associated with the 
stressor. 
C.      Actual or preferred avoidance of circumstances resembling or associated with the stressor (not 
present before exposure to the stressor). 
D.     Either (1) or (2): 
(1)     Inability to recall, either partially or completely, some important aspects of the period of exposure to the 
stressor 
(2)       Persistent symptoms of increased psychological sensitivity and arousal (not present before exposure to the 
stressor) shown by any two of the following: 
a) difficulty in falling or staying asleep; 
b) irritability or outbursts of anger; 
c) difficulty in concentrating; 
d) hyper-vigilance; 
e) exaggerated startle response 
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The aim of the current paper is to review the 
contemporary literature, which reports the 
economic burden of PTSD. 
 
Search Strategy 
A broad search was initially undertaken to 
identify relevant studies. PTSDPubs, the 
Cumulative Index of Nursing and Allied Health 
Literature (CINAHL), PubMed and Psych Info 
were used to identify studies reporting the 
economic cost of PTSD. Keywords used were 
“Cost of Illness” OR “Economic burden of 
disease” in PTSDPubs. “Cost of Illness”, 
“Burden of Disease” “PTSD” and 
“Psychological Trauma” were used in the other 
databases. The search took place on 21 May 
2019. There was a paucity of primary research 
identified. A sum total of three studies are 
apparent that report the economic burden of 
PTSD [15,16,3]. These are discussed below. 
 
Economic Burden of PTSD 
McCrone et al [17] commented that, whilst 
economic evaluations of interventions for 
mental health problems had been undertaken 
none existed for PTSD. McCrone et al [17] also 
claim cost of illness studies had not been 
undertaken for PTSD. It would appear little has 
happened since. Ferry et al [15], in what they 
assert is the first cost-of illness study of PTSD 
globally, examined the economic impact of 
PTSD in Northern Ireland (NI).  Ferry et al [15] 
adopted a prevalence based, bottom up 
approach (Thomas & Morris) [18] approach to 
calculating the total cost of PTSD in NI in 2008.  
Direct costs they included were the cost of 
medications and visits to service providers. 
Indirect costs collated were lost productivity 
due to absenteeism and presenteeism. They 
conducted a secondary analysis of data 
collected for the Northern Ireland Study of 
Health and Stress (NISHS) in 2008 and 
estimated a 12-month prevalence rate of PTSD 
in NI as 5.1% (approximately 75,000 adults). 
They estimate 318,815 individual contacts, 
based on the estimate of 75,000 service users, 
with healthcare providers at an estimated cost 
of £27,317,184. Medication costs were 
estimated to be £5,658,406, of which £5 million 
was for anti-depressants, anxiolytics and anti-
psychotics.  
 
Ferry et al [15] report 2,283,130 days lost to 
work in 2008 as a result of PTSD. This 
accounted for 66% of all direct and indirect 
costs and is reported as £113,564,751. 
Presenteeism, the amount lost by sub-standard 
work [19], was estimated to cost £ 26,215,721 
in 2008. It should be highlighted that Ferry et al 
[15]do not differentiate between statutory, 
private and voluntary providers in their 
calculations.  
 
Fuchkan Buljan [16] reports, as part of a larger 
study, the social and economic cost of PTSD 
following the London Bombings in July 2005. 
She surveyed 230 clients attending NHS 
services in London having been affected by the 
bombings. Two hundred and five had been 
directly involved in the bombing and 179 
witnessing a serious injury to others or a death. 
Fuchkan Buljan [16] adopted a bottom up 
approach using a health and social care 
perspective. Direct costs included health 
service usage (private, statutory and voluntary 
sectors) and medication costs. Indirect costs 
were costs due to sick leave, unemployment and 
reduced work hours. The productivity lost by 
sick leave, unemployment and hours reduced is 
reported as £777,596.26, £544,627.12 and 
£63,932.16 respectively. Direct service costs 
are summarized in Table 1. Fuchkan Buljan 
[16] does not appear to report a total number of 
days lost, rather she provides ranges of sick 
leave from 1 to 1112 days lost. She also reports 
that 29 people in her sample (total n=230) 
reduced their work hours and where people 
were made unemployed that period of 
unemployment ranged from 3 to 320 weeks. 
 
In a brief report investigating the clinical and 
economic burden of PTSD in Vietnam War 
veterans, Wang et al [3] focused on the direct 
healthcare costs (in-patient, out-patient and 
pharmacy) associated with a diagnosis of 
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PTSD. Drawing their sample from the Veterans 
Health Association (VHA) database of veterans 
diagnosed with PTSD (n=492,546) they report 
that, on average, hospital in-patient costs 
incurred were $5,486 per person. Mean 
outpatient treatment costs are reported as 
$10,057/ person and pharmacy costs as $1.207 
per person. The mean total cost incurred per 
person was $16,750 [3]. 
 









112,356.30 331,185.60 113,642.06 374,960.00 4296.23 51919.00 15004.84 
The three studies above appear to represent the 
global sum total of studies examining the cost 
of PTSD. Table 2 summarizes the direct and 
indirect costs reported in the papers. The 
difference in perspectives used and methods of 
data collection make comparison and synthesis 
difficult. However, it is apparent that there is a 
substantial economic cost associated with 
PTSD. This is particularly evident in the study 
by Wang et al [3], who include costs associated 
with common physical ailments associated with 
PTSD, such as hypertension.  
 











Total cost of 
illness 


















£1,003,364.03 £1,386,156.22 £2,289,520.45 




None $8,250,145,500  $8,250,145,500* 
*Wang et al (2016) report a mean cost of $16750 per veteran. Total cost reported above calculated by 
multiplying by sample size n=492,546 
Both Ferry et al [15] and Fuchkan Buljan [16] 
both report a high proportion of indirect costs 
as part of the total cost estimate for PTSD. 
However, they are both limited in what they 
include as an indirect cost. Goodman (2014) 
suggests that indirect costs can include lost or 
impaired leisure activity and other measurable 
but not directly related to healthcare costs. 
Curran et al [20] attempted to calculate the total 
impact of experiencing a traumatic event. 
Drawing from data collected from 2191 patients 
in NI they report that a number of social factors 
can have an impact on individual and 
subsequently on society. For example, Fuchkan 
Buljan [16] reports on the cost of being made 
unemployed, however Curran et al highlight 
that having to change jobs as a result of the 
traumatic incident has almost the same impact 
on the individual. Given that Fuchkan Buljan 
[16] included being made unemployed as an 
indirect cost and extrapolated from an 
individual up to a healthcare perspective. It is 
reasonable to posit that, noting Curran et al’s 
[20] findings, that she has underestimated the 
indirect costs of the London Bombings by not 
including a cost associated with changing jobs. 
 
Similarly, Curran et al [20] found that being 
hospitalized in a mental health hospital had 
twice as much negative impact as admission to 
hospital for physical injuries after a traumatic 
event. None of the included studies appear to 
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differentiate between admission to hospital for 
physical issues related to the traumatic incident 
and admission to a psychiatric unit for a period 
of time.  
 
McCrone et al [17] argue that the economic 
effects of PTSD impact the family, employer 
and wider society. Again, none of three studies 
examined the economic impact of PTSD on this 
wider circle leading to an underestimation of 
the true economic cost. Being forced to move 
house as a result of a traumatic event is again 
noted to impact on the psycho-social wellbeing 
of an individual (Curran et al) [20]. Whilst one 
can argue that the healthcare perspective 
adopted by Wang et al (2016) [3] and Fuchkan 
Buljan [15] would not take into account these 
factors, Rumbold et al [21], for example, note 
that house moves during early childhood can 
have a negative impact on a child’s mental 
health.  
 
Notwithstanding this lack of evidence, the 
economic cost of PTSD is substantial and 
potentially long lasting; Bunting et al [14] 
report that in NI, patients wait on average 22 
years after the onset of disease before seeking 
professional help. Cognitive Behavioral 
Therapy (CBT) is recommended by the United 
Kingdom National Institute for Health and Care 
Excellence (NICE) as first line treatment for 
PTSD. In their recent guidance, NICE (2018) 
report five economic evaluations of 
interventions. Trauma-Focus CBT (TF-CBT) 
was dominant (more clinically effective at less 
cost (York Health Economics Consortium 
(2016) [22-24] than Prolonged Exposure, no 
treatment and Sertraline. Non trauma focused 
CBT resulted in lower costs but worse 
outcomes when compared to psychoeducation. 
Mihalopous et al adopted a cost utility approach 
to TF-CBT versus Treatment as Usual. They 
report an incremental cost-effective ratio of 
19,000 AUD/ QALY gained. They conclude 
that TF-CBT is more cost effective that 
Treatment as Usual for people experiencing 
symptoms of PTSD. Ferry et al [15] estimate 
that it would cost £102million to treat all 




The small number of papers included in review 
make it difficult to make definitive conclusions 
about the overall economic burden of PTSD. 
Whilst a broad-brush approach to identifying 
literature used, it did not include searches for 
grey literature, nor were papers included that 
examined the economic burden of anxiety 
disorders. As such some reports of the 
economic burden of PTSD may be missing 
from this review. 
 
Conclusion 
In addition to the personal cost of PTSD, 
the economic impact of PTSD is 
substantial. In healthcare systems where 
resources are scarce it is important to 
properly quantify the impact of not only 
healthcare interventions but also the 
underlying cost of the illnesses. The papers 
reviewed show a substantial economic cost 
to healthcare systems and to society as a 
whole. However, it is likely given the small 
number of studies, the limitations inherent 
in the studies above and the narrow 
parameters adopted in each of them that the 
economic cost of PTSD is being 
underestimated. A wide-ranging, societal 
perspective examination of the cost of 
PTSD is required. Additionally, cost 
effectiveness studies of clinically effective 
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